Astellas Pharma
4503.T
#1000
Rank
$18.37 B
Marketcap
$10.25
Share price
-0.85%
Change (1 day)
-29.70%
Change (1 year)

Operating Margin for Astellas Pharma (4503.T)

Operating Margin as of April 2024 (TTM): 9.75%

According to Astellas Pharma's latest financial reports and stock price the company's current Operating Margin is 9.75%. At the end of 2022 the company had an Operating Margin of 12.49%.

Operating Margin history for Astellas Pharma from 2009 to 2023

Operating Margin at the end of each year

Year Operating Margin Change
202212.49%5.66%
202111.82%-38.1%
202019.09%-0.35%
201919.16%13.29%
201816.91%-21.83%
201721.63%12.74%
201619.19%24.16%
201515.45%42.49%
201410.85%-12.71%
201312.42%-5.31%
201213.12%5.03%
201112.49%-47.63%
201023.86%-21.43%
200930.37%9.86%
200827.64%19.97%
200723.04%13.53%
200620.29%27.06%
200515.97%-21.34%
200420.30%

What is a company's Operating Margin

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.